Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours

This publication has 21 references indexed in Scilit:

• The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
  Clinical Therapeutics, 1996
• Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril
  Journal Of Hypertension, 1996
• Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin‐II Antagonist
  Cardiovascular Drug Reviews, 1995
• Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects
  European Journal of Clinical Pharmacology, 1994
• New Therapeutic Agents in the Management of Hypertension: Angiotensin II-Receptor Antagonists and Renin Inhibitors
  Annals of Pharmacotherapy, 1993
• Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT₁‐receptor subtype
  British Journal of Pharmacology, 1993
• Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents
  The American Journal of Medicine, 1993
• The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension
  Journal Of Hypertension, 1992
• Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context
  Published by Elsevier ,1990
• Role of blood pressure in cardiovascular morbidity and mortality
  Progress in Cardiovascular Diseases, 1974